Where did you work before you joined Synpromics?
I studied at the University of Edinburgh for my PhD in chemistry in 2001 before helping to start Lab901 (Scottish SME) where I was Product Development Manager responsible for developing the TapeStation and ScreenTape technologies from concept to market success. Lab901 was acquired by Agilent Technologies (US multinational) in 2011 where I became R&D Director for the Microfluidics Business taking responsibility for setting the R&D strategy and leading the team through tremendous business growth. My principle roles have been in R&D but the journey form start-up to multinational has given me a breadth of experience in business operations, financial planning, intellectual property, and quality/compliance.
Why did you decide to join Synpromics?
Many reasons. I have a passion for young companies where everything is possible. The Synpromics team have a perfect blend of experience, enthusiasm, and creativity. Synthetic biology is a fantastically exciting area of science and with Synpromics technology we have the opportunity to achieve something special. With our work in gene therapy and with our collaborators we have the chance of doing some good.
What is your role and what do you enjoy most about it?
I love problem solving and making things happen. As Director of Operations I get to help put the building blocks in place and bringing people together to deliver on our promises.